BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7090937)

  • 21. [Acylated tripeptides as chemotaxin antagonists (author's transl)].
    Opitz W; Fruchtmann R
    Hoppe Seylers Z Physiol Chem; 1981 Aug; 362(8):1037-41. PubMed ID: 7346374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diverging effects of chemotactic serum peptides and synthetic f-Met-Leu-Phe on neutrophil locomotion and adhesion.
    Keller HU; Wissler JH; Damerau B
    Immunology; 1981 Mar; 42(3):379-83. PubMed ID: 7203527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemotaxis of horse polymorphonuclear leukocytes to N-formyl-L-methionyl-L-leucyl-L-phenylalanine.
    Zinkl JG; Brown PD
    Am J Vet Res; 1982 Apr; 43(4):613-6. PubMed ID: 7073083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipomodulin: a possible mediator of the action of glucocorticoids.
    Hirata F
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():73-8. PubMed ID: 6221579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracellular control of human neutrophil secretion. II. Stimulus specificity of desensitization induced by six different soluble and particulate stimuli.
    Henson PM; Schwartzman NA; Zanolari B
    J Immunol; 1981 Aug; 127(2):754-9. PubMed ID: 7019331
    [No Abstract]   [Full Text] [Related]  

  • 26. [Oriented migration of rat polymorphonucleocytes induced by 4-hydroxynonenal and formylmethionyl-leucyl-phenylalanine].
    Curzio M; Torriello MV; Dianzani MU
    Boll Soc Ital Biol Sper; 1982 Dec; 58(24):1672-8. PubMed ID: 6897768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitors of monocyte responses to chemotaxins are associated with human neoplasms.
    Snyderman R; Cianciolo G
    Adv Exp Med Biol; 1982; 155():343-52. PubMed ID: 7158488
    [No Abstract]   [Full Text] [Related]  

  • 28. Methyl ester of N-formylmethionyl-leucyl-phenylalanine: chemotactic responses of human blood monocytes and inhibition of gold compounds.
    Ho PP; Young AL; Southard GL
    Arthritis Rheum; 1978; 21(1):133-6. PubMed ID: 414757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of human polymorphonuclear leukocyte superoxide release by cellular responses to chemotactic peptides.
    English D; Roloff JS; Lukens JN
    J Immunol; 1981 Jan; 126(1):165-71. PubMed ID: 6256437
    [No Abstract]   [Full Text] [Related]  

  • 30. Chemotaxis in vitreous haemorrhage: an experimental study.
    LaNauze JH; Hembry RM; Jacobson W; Watson PG
    Exp Eye Res; 1982 May; 34(5):803-13. PubMed ID: 7084341
    [No Abstract]   [Full Text] [Related]  

  • 31. A monoclonal antibody-inhibiting FMLP-induced chemotaxis of human neutrophils.
    Cotter TG; Keeling PJ; Henson PM
    J Immunol; 1981 Dec; 127(6):2241-5. PubMed ID: 7053244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on stimulus-response coupling in human neutrophils. I. Role of monovalent cations in the respiratory and secretory response to N-formylmethionylleucylphenylalanine.
    Della Bianca V; Bellavite P; De Togni P; Fumarulo R; Rossi F
    Biochim Biophys Acta; 1983 Feb; 755(3):497-505. PubMed ID: 6824740
    [No Abstract]   [Full Text] [Related]  

  • 33. Defective neutrophil chemotaxis resulting from thermal injury: restoration of directed migration by increasing Boyden chamber filter pore size.
    Stein MD; Stevens JM; Herndon DN
    Clin Immunol Immunopathol; 1983 May; 27(2):234-9. PubMed ID: 6872354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neutrophil dysfunction in sepsis. II. Evidence for the role of complement activation products in cellular deactivation.
    Solomkin JS; Jenkins MK; Nelson RD; Chenoweth D; Simmons RL
    Surgery; 1981 Aug; 90(2):319-27. PubMed ID: 7256544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytoplasmic microtubules in polymorphonuclear leukocytes: effects of chemotactic stimulation and colchicine.
    Anderson DC; Wible LJ; Hughes BJ; Smith CW; Brinkley BR
    Cell; 1982 Dec; 31(3 Pt 2):719-29. PubMed ID: 7159932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of calmodulin in granulocyte chemotaxis: the effect of calmodulin inhibitors.
    Elferink JG; Deierkauf M; Riemersma JC
    Res Commun Chem Pathol Pharmacol; 1982 Oct; 38(1):77-84. PubMed ID: 7146623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of 6,9-deepoxy-6,9-(phenylimino)-delta 6,8-prostaglandin 1(1) (U-60,257), an inhibitor of leukotriene synthesis, on human neutrophil function.
    Smith RJ; Sun FF; Bowman BJ; Iden SS; Smith HW; McGuire JC
    Biochem Biophys Res Commun; 1982 Dec; 109(3):943-9. PubMed ID: 6297495
    [No Abstract]   [Full Text] [Related]  

  • 38. The roles of degranulation and superoxide anion generation in neutrophil aggregation.
    Kaplan HB; Edelson HS; Friedman R; Weissmann G
    Biochim Biophys Acta; 1982 Sep; 721(1):55-63. PubMed ID: 6289915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymorphonuclear leukocyte function in psoriasis: chemotaxis, chemokinesis, beta-adrenergic receptors, and proteolytic enzymes of polymorphonuclear leukocytes in the peripheral blood from psoriatic patients.
    Fräki JE; Jakoi L; Davies AO; Lefkowitz RJ; Snyderman R; Lazarus GS
    J Invest Dermatol; 1983 Sep; 81(3):254-7. PubMed ID: 6309987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Receptor-directed inhibition of chemotactic factor-induced neutrophil hyperactivity by pyrazolon derivatives. Definition of a chemotactic peptide antagonist.
    Dahinden C; Fehr J
    J Clin Invest; 1980 Nov; 66(5):884-91. PubMed ID: 7430350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.